No shortage on file

SODIUM BICARBONATE INJECTION USP

STERIMAX INC

Quick answers

Is there a shortage of SODIUM BICARBONATE INJECTION USP in Canada?

No. There is no current shortage of SODIUM BICARBONATE INJECTION USP 84MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file5 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SODIUM BICARBONATE INJECTION 84MG/ML

ASTRAZENECA CANADA INC

84MG · DIN 00701572

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SODIUM BICARBONATE INJ 4.2%

INTERNATIONAL MEDICATION SYSTEMS LTD.

42MG · DIN 00243914

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SODIUM BICARBONATE INJ 7.5%

INTERNATIONAL MEDICATION SYSTEMS LTD.

75MG · DIN 00243922

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SODIUM BICARBONATE TAB 600MG

D.C. LABS LIMITED

600MG · DIN 00221619

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

800 SODIUM BICARBONATE POWDER

BAXTER CORPORATION

650G · DIN 00774995

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP

EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.

Type I2025-07-28

Highest health risk

Possible match — not confirmed

Sodium Acetate Injection USP

Sodium Acetate Injection USP; Incorrect GTIN

Type II2025-03-05

Moderate health risk

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter

2022-03-15

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP: Particulate matter

Type I2022-03-07

Highest health risk

Possible match — not confirmed

DIN

02541904

Strength

84MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

SODIUM BICARBONATE

See all SODIUM BICARBONATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2024-11-21

Shortage Avoided

Delay in shipping of the drug.

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890